5-amino-1mq contraindications – Vionex 5-amino-1mq dosing protocol subcutaneous injection

Method Suitability Validate assay selectivity, recovery, concentration range, controls, and matrix effects

We have the highest regard for Dr Learys professionalism and results

Erysipelatoclostridium is a member of the Erysipelotrichaceae family, which has been linked to obesity and related metabolic issues 59

A BHRC physician will evaluate your medical history, current health status, and goals to determine if 5-Amino-1MQ is appropriate for you

Why Compounding Access Is Not an Established Path Positioning in the Metabolic Medicine Conversation For physicians fielding patient questions about 5-amino-1MQ, the appropriate framing: Promising mechanism with solid preclinical rationale Early clinical development human efficacy and safety not yet well characterized No legitimate clinical access pathway in the United States as of 2026 Alternative evidence-based options exist for the underlying metabolic optimization goals patients typically pursue Key Takeaways 5-amino-1MQ is a small-molecule NNMT inhibitor, not a peptide